171 related articles for article (PubMed ID: 25417235)
1. The impact of state-specific life tables on relative survival.
Stroup AM; Cho H; Scoppa SM; Weir HK; Mariotto AB
J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):218-27. PubMed ID: 25417235
[TBL] [Abstract][Full Text] [Related]
2. Adjusting relative survival estimates for cancer mortality in the general population.
Ellison LF
Health Rep; 2014 Nov; 25(11):3-9. PubMed ID: 25408490
[TBL] [Abstract][Full Text] [Related]
3. Neighborhood and Individual Socioeconomic Disadvantage and Survival Among Patients With Nonmetastatic Common Cancers.
Cheng E; Soulos PR; Irwin ML; Cespedes Feliciano EM; Presley CJ; Fuchs CS; Meyerhardt JA; Gross CP
JAMA Netw Open; 2021 Dec; 4(12):e2139593. PubMed ID: 34919133
[TBL] [Abstract][Full Text] [Related]
4. Expected years of life lost for six potentially preventable cancers in the United States.
Liu PH; Wang JD; Keating NL
Prev Med; 2013 May; 56(5):309-13. PubMed ID: 23428566
[TBL] [Abstract][Full Text] [Related]
5. Cancer survival in five continents: a worldwide population-based study (CONCORD).
Coleman MP; Quaresma M; Berrino F; Lutz JM; De Angelis R; Capocaccia R; Baili P; Rachet B; Gatta G; Hakulinen T; Micheli A; Sant M; Weir HK; Elwood JM; Tsukuma H; Koifman S; E Silva GA; Francisci S; Santaquilani M; Verdecchia A; Storm HH; Young JL;
Lancet Oncol; 2008 Aug; 9(8):730-56. PubMed ID: 18639491
[TBL] [Abstract][Full Text] [Related]
6. Life tables for world-wide comparison of relative survival for cancer (CONCORD study).
Baili P; Micheli A; De Angelis R; Weir HK; Francisci S; Santaquilani M; Hakulinen T; Quaresmas M; Coleman MP;
Tumori; 2008; 94(5):658-68. PubMed ID: 19112937
[TBL] [Abstract][Full Text] [Related]
7. Assessing non-cancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence.
Cho H; Mariotto AB; Mann BS; Klabunde CN; Feuer EJ
Am J Epidemiol; 2013 Aug; 178(3):339-49. PubMed ID: 23825168
[TBL] [Abstract][Full Text] [Related]
8. Long-term cancer patient survival in the United States.
Wingo PA; Ries LA; Parker SL; Heath CW
Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):271-82. PubMed ID: 9568781
[TBL] [Abstract][Full Text] [Related]
9. Cancer mortality surveillance--United States, 1990-2000.
Stewart SL; King JB; Thompson TD; Friedman C; Wingo PA
MMWR Surveill Summ; 2004 Jun; 53(3):1-108. PubMed ID: 15179359
[TBL] [Abstract][Full Text] [Related]
10. Leading cancers--changes in five-year relative survival.
Ellison LF; Gibbons L
Health Rep; 2004 Mar; 15(2):19-32. PubMed ID: 15151028
[TBL] [Abstract][Full Text] [Related]
11. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study.
Clegg LX; Reichman ME; Miller BA; Hankey BF; Singh GK; Lin YD; Goodman MT; Lynch CF; Schwartz SM; Chen VW; Bernstein L; Gomez SL; Graff JJ; Lin CC; Johnson NJ; Edwards BK
Cancer Causes Control; 2009 May; 20(4):417-35. PubMed ID: 19002764
[TBL] [Abstract][Full Text] [Related]
12. Five-year relative survival from prostate, breast, colorectal and lung cancer.
Ellison LF; Gibbons L;
Health Rep; 2001 Dec; 13(1):23-34. PubMed ID: 15069806
[TBL] [Abstract][Full Text] [Related]
13. Mortality rates by stage-at-diagnosis.
Clinton K
Semin Surg Oncol; 1994; 10(1):7-11. PubMed ID: 8115787
[TBL] [Abstract][Full Text] [Related]
14. Estimates and projections of value of life lost from cancer deaths in the United States.
Yabroff KR; Bradley CJ; Mariotto AB; Brown ML; Feuer EJ
J Natl Cancer Inst; 2008 Dec; 100(24):1755-62. PubMed ID: 19066267
[TBL] [Abstract][Full Text] [Related]
15. Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study.
Clegg LX; Li FP; Hankey BF; Chu K; Edwards BK
Arch Intern Med; 2002 Sep; 162(17):1985-93. PubMed ID: 12230422
[TBL] [Abstract][Full Text] [Related]
16. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data.
Coleman MP; Forman D; Bryant H; Butler J; Rachet B; Maringe C; Nur U; Tracey E; Coory M; Hatcher J; McGahan CE; Turner D; Marrett L; Gjerstorff ML; Johannesen TB; Adolfsson J; Lambe M; Lawrence G; Meechan D; Morris EJ; Middleton R; Steward J; Richards MA;
Lancet; 2011 Jan; 377(9760):127-38. PubMed ID: 21183212
[TBL] [Abstract][Full Text] [Related]
17. Life tables for global surveillance of cancer survival (the CONCORD programme): data sources and methods.
Spika D; Bannon F; Bonaventure A; Woods LM; Harewood R; Carreira H; Coleman MP; Allemani C
BMC Cancer; 2017 Feb; 17(1):159. PubMed ID: 28241815
[TBL] [Abstract][Full Text] [Related]
18. Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival.
Hu CY; Xing Y; Cormier JN; Chang GJ
Cancer; 2013 May; 119(10):1900-7. PubMed ID: 23408226
[TBL] [Abstract][Full Text] [Related]
19. Timely disclosure of progress in long-term cancer survival: the boomerang method substantially improved estimates in a comparative study.
Brenner H; Jansen L
J Clin Epidemiol; 2016 Feb; 70():224-32. PubMed ID: 26456902
[TBL] [Abstract][Full Text] [Related]
20. Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers.
Charvat H; Bossard N; Daubisse L; Binder F; Belot A; Remontet L
Cancer Epidemiol; 2013 Dec; 37(6):857-63. PubMed ID: 24063904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
